Suchergebnisse - "Menter, Alan"

PubPharm (507)

71

The Validity of Cutaneous Body Image as a Construct and as a Mediator of the Relationship Between Cutaneous Disease and Mental Health

enthalten in: Dermatology and therapy | 2020

von Hinkley, S. | Holub, S. | Menter, A.

72

Tildrakizumab efficacy and safety are not altered by metabolic syndrome status in patients with psoriasis : Post hoc analysis of 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2)

enthalten in: Journal of the American Academy of Dermatology | 2020

von Lebwohl, M. | Leonardi, C. | Mehta, N. | +5

73

Clinical and Molecular Effects of Interleukin-17 Pathway Blockade in Psoriasis

enthalten in: Journal of drugs in dermatology : JDD | 2020

von Green, L. | Weinberg, J. | Menter, A. | +3

74

The Validity of Cutaneous Body Image as a Construct and as a Mediator of the Relationship Between Cutaneous Disease and Mental Health

enthalten in: Dermatology and therapy | 2020

von Hinkley, S. | Holub, S. | Menter, A.

75

IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis

enthalten in: The Journal of investigative dermatology | 2020

von Callewaert, C. | Nakatsuji, T. | Knight, R. | +14

CommentIn: J Invest Dermatol. 2020 Jan;140(1):15-17. - PMID 31864429

76

Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients

enthalten in: Journal of the American Academy of Dermatology | 2020

von Menter, A. | Cordoro, K. | Davis, D. | +29

ErratumIn: J Am Acad Dermatol. 2020 Mar;82(3):574. - PMID 32057334

77

Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study

enthalten in: American journal of clinical dermatology | 2019

von Lebwohl, M. | Blauvelt, A. | Menter, A. | +5

78

Initial skin cancer screening for solid organ transplant recipients in the United States : Delphi method development of expert consensus guidelines

enthalten in: Transplant international : official journal of the European Society for Organ Transplantation | 2019

von Crow, L. | Jambusaria-Pahlajani, A. | Chung, C. | +83

CommentIn: Transpl Int. 2019 Dec;32(12):1244-1246. - PMID 31610049

79

Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study

enthalten in: American journal of clinical dermatology | 2019

von Lebwohl, M. | Blauvelt, A. | Menter, A. | +5

80

Injection Site Reactions in the Federal Adverse Event Reporting System (FAERS) Post-Marketing Database Vary Among Biologics Approved to Treat Moderate-To-Severe Psoriasis

enthalten in: Dermatology and therapy | 2019

von Grace, E. | Goldblum, O. | Renda, L. | +4